Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | [F-18] Fluorodopa Positron Emission Tomography | - | - | - | - | [1] 6 6 |
| 2 | Positron Emission Tomography | - | - | - | - | [4] 40 40, 46, 49, 96 |
| 3 | Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin) | [1] Activated charcoal Activated charcoal | - | - | - | [1] 6 6 |
| 4 | Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin) | - | - | - | - | [1] 6 6 |
| 5 | Radiation: PET (Positron Emission Tomography) Study | - | - | - | - | [1] 17 17 |